Free Trial

AlloVir (ALVR) Earnings Date, Estimates & Call Transcripts

$0.77
-0.01 (-1.01%)
(As of 04:29 PM ET)

Earnings Summary

Upcoming
Earnings Date
Aug. 1Estimated
Actual EPS
(May. 13)
-$0.18 Missed By -$0.02
Consensus EPS
(May. 13)
-$0.16
Skip Charts & View Estimated and Actual Earnings Data

ALVR Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ALVR Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

AlloVir Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241($0.15)($0.15)($0.15)
Q2 20241($0.04)($0.04)($0.04)
Q3 20241($0.02)($0.02)($0.02)
Q4 20241($0.02)($0.02)($0.02)
FY 20244($0.23)($0.23)($0.23)

ALVR Earnings Date and Information

AlloVir last released its quarterly earnings data on May 13th, 2024. The reported ($0.18) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.16) by $0.02. AlloVir has generated ($1.66) earnings per share over the last year (($1.66) diluted earnings per share). Earnings for AlloVir are expected to decrease in the coming year, from ($0.27) to ($0.36) per share. AlloVir has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off prior year's report dates.

AlloVir Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/1/2024
(Estimated)
------- 
5/13/2024Q1 2024($0.16)($0.18)($0.02)($0.10)--
3/15/2024Q4 2023($0.43)($0.53)($0.10)($0.53)--
11/2/2023Q3 2023($0.42)($0.39)+$0.03($0.39)--
8/3/2023Q2 2023($0.45)($0.48)($0.03)($0.48)--
5/4/2023Q1 2023($0.47)($0.44)+$0.03($0.44)--
2/15/2023Q4 2022($0.51)($0.37)+$0.14($0.37)--
11/3/2022Q3 2022($0.52)($0.50)+$0.02($0.50)--
8/4/2022Q2 2022($0.70)($0.69)+$0.01($0.69)--
5/5/2022Q1 2022($0.74)($0.69)+$0.05($0.69)--
2/10/2022Q4 2021($0.71)($0.92)($0.21)($0.92)--    
11/5/2021Q3 2021($0.59)($0.72)($0.13)($0.72)--
8/5/2021Q2 2021($0.46)($0.60)($0.14)($0.60)--
5/5/2021Q1 2021($0.40)($0.50)($0.10)($0.50)--
11/15/2020Q3 2020($0.30)($0.58)($0.28)($0.58)--
9/2/2020Q2 2020($0.31)($4.43)($4.12)($4.43)--

AlloVir Earnings - Frequently Asked Questions

When is AlloVir's earnings date?

AlloVir has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off last year's report dates. Learn more on ALVR's earnings history.

Did AlloVir beat their earnings estimates last quarter?

In the previous quarter, AlloVir (NASDAQ:ALVR) missed the analysts' consensus estimate of ($0.16) by $0.02 with a reported earnings per share (EPS) of ($0.18). Learn more on analysts' earnings estimate vs. ALVR's actual earnings.

How much profit does AlloVir generate each year?

AlloVir (NASDAQ:ALVR) has a recorded net income of -$190.42 million. ALVR has generated -$1.66 earnings per share over the last four quarters.

What is AlloVir's EPS forecast for next year?

AlloVir's earnings are expected to decrease from ($0.27) per share to ($0.36) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:ALVR) was last updated on 6/25/2024 by MarketBeat.com Staff

From Our Partners